← Back to Clinical Trials
Recruiting NCT06760754

NCT06760754 Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06760754
Status Recruiting
Phase
Sponsor M.D. Anderson Cancer Center
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-03-31
Primary Completion 2028-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Digital culinary medicine intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-03-31 with a primary completion date of 2028-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to develop and test the feasibility of a theory-driven digital culinary medicine program among food insecure cancer survivors referred from the University of Texas MD Anderson Cancer Center Oncology Clinic at LBJ to the LBJ Food Farmacy program.

Eligibility Criteria

Inclusion Criteria: * Cancer survivors treated at the MD Anderson Oncology Program at LBJ Hospital over 18 years of age. * Screen positive for food insecurity using the 2 question clinic-screener (Hunger Vital Signs) * Receive referral to the LBJ Food Farmacy. * Are within the first 5 years off of acute cancer treatment. * Self-report having internet access. * Self-report as being able to speak and read English or Spanish. * Willing to complete study assessments. Exclusion Criteria: * Unwilling or unable to complete study assessments * Anyone under 18 years of age * Self-report to not speak or read English or Spanish

Contact & Investigator

Central Contact

Maria Vazquez

✉ mrvazquez1@mdanderson.org

📞 713-792-7124

Principal Investigator

Margaret Raber, DRPH

PRINCIPAL INVESTIGATOR

M.D. Anderson Cancer Center

Frequently Asked Questions

Who can join the NCT06760754 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06760754 currently recruiting?

Yes, NCT06760754 is actively recruiting participants. Contact the research team at mrvazquez1@mdanderson.org for enrollment information.

Where is the NCT06760754 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT06760754 clinical trial?

NCT06760754 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Margaret Raber, DRPH at M.D. Anderson Cancer Center. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology